Search

everythinglearnresearchcommunity

for

Search:↓

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

Complex basal cell carcinomas need personalized treatment due to unique genetic mutations.

Higher PSA levels can indicate prostate cancer, but there's overlap with non-cancerous conditions.

Trichoblastic carcinoma may be a distinct type of skin cancer different from basal cell carcinoma.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

PTCH gene mutations contribute to basal cell carcinoma development.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

Cholesteatoma shows abnormal and increased EGF receptor expression, indicating its rapid growth.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Mouse skin cancer progression involves a unique group of cells marked by ABCG2 and MTS24.

Colorectal cancer's ability to spread is due to changes in many genes, not just one.

Pygopus 2 helps ovarian cancer cells grow by aiding ribosomal RNA production, independent of Wnt signaling.

Mice with human-like EGFR had growth issues, skin defects, heart problems, and unusual bone development.

A postmenopausal woman's hormone imbalance and symptoms improved after removing benign ovarian tumors.

The tumor likely shows dual neural crest differentiation.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

Basal cell carcinomas need extra mutations to grow from small to large tumors.

Some breast cancer chemotherapy can cause permanent hair loss.

Researchers created hair-inducing human cell clusters using a 3D culture method.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.